Innovative new technology has been used to identify and profile a novel combination of proteins that may improve treatment for prostate disorders. [ + ]

Sigma-Aldrich has acquired all outstanding shares of Cleveland-based company Research Organics to expand its buffer production capacity and to increase its portfolio of PharmaGrade raw materials for the biopharmaceutical and diagnostic markets. [ + ]

There’s no gene for genius, but scientists have found that a tiny change in a single gene has an impact on brain size and general intelligence. [ + ]

Science is set to become one of the hottest subjects on the timetable for students in Years Nine and 10, following the launch of the inaugural Science for Growth Awards. The awards are being piloted in New South Wales and Queensland before a national launch in 2013. [ + ]

Researchers have uncovered why some individuals with X-linked lymphoproliferative live far longer than expected, which could lead to a gene therapy for the disease. [ + ]

Researchers have uncovered why some individuals with X-linked lymphoproliferative live far longer than expected, which could lead to a gene therapy for the disease. [ + ]

RMIT will sell its toxicology testing unit, RDDT, to vivoPharm Technologies in exchange for a 20% stake in the contract research organisation (CRO). [ + ]

An international collaborative study including researchers from The University of Western Australia (UWA) has identified at least two new gene variants that increase the risk of common childhood obesity. [ + ]

An international scientific team has carried out the world’s first analysis of the impact of ocean acidification on every gene in the coral genome, throwing new light on the likely fate of corals under climate change. [ + ]

The Government of South Australia has announced it will fund a new $1 million initiative over three years to help South Australia’s three main universities seek patent protection for their intellectual property (IP). [ + ]

The capacity of the Prime Minister’s Science, Engineering and Innovation Council (PMSEIC) has been reinforced by a $10 million government commitment to the Council’s new arrangements. [ + ]

Tiny agents found in omega-3 could potentially be used to block the path of primary cancer tumours, preventing the advance to secondary stage cancers, according to pharmacy researchers at the University of Sydney. [ + ]

QRxPharma (ASX:QRX) has completed two phase 1 trials of its MoxDuo CR dual-opioid tablets, and revealed some positive pharmacokinetic results. [ + ]

NSW-based biotech Sirtex Medical (ASX:SRX) said Q3 dose sales of its SIR-Spheres microspheres liver cancer treatment a record grew 34% year-on-year. [ + ]

Gliolan, a drug licensed to Melbourne's STA which has the ability to make brain tumours glow red during neurosurgery, has been granted orphan drug status by the TGA. [ + ]